NCT02022150Unknown不适用
Body Composition Analysis in Cirrhotic Patients With Ascites Undergoing Paracentesis
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年12月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Body composition
研究概览
简要总结
Ascites is a frequent complication of liver cirrhosis, initial treatment consists on diuretics intake, however, as the disease progresses this complication becomes more severe, consequently other therapeutic options are used.
Paracentesis is indicated when severe ascites is present and it should be accompanied by albumin infusion.
Nutritional status is generally affected in patients with liver cirrhosis, even more patients with severe ascites show decreased energy intake due to gastric compression.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Any genre.
- •Age 18-70 years old.
- •Diagnosis of liver cirrhosis of any etiology (documented by clinical, biochemical, radiological and / or biopsy.
- •Presence of high volume ascites
- •The signing of informed consent will be required for the inclusion of any patient.
排除标准
- •Hepatic encephalopathy grade III or IV. 2) liver transplantation.
- •Congestive heart failure.
- •Hemodialysis.
- •Acute or chronic renal failure.
- •Nephrotic syndrome with protein loss.
- •Alcoholism active in the last 6 months.
- •Pregnancy.
- •upper gastrointestinal bleeding.
结局指标
主要结局
Body composition
时间窗: Baseline and 8 days post treatment
bioelectrical impedance vector analysis
次要结局
未报告次要终点
研究者
ALDO TORRE DELGADILLO
M.D. M.Sc
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the Association Between Imaging and Clinical ParametersCirrhosisNCT05157308Asian Institute of Gastroenterology, India385
已完成
不适用
Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXALiver CirrhosisNCT02421848University of Sao Paulo112
已完成
1 期
Empagliflozin in Diuretic Refractory AscitesAscitesAscites HepaticSodium-Glucose Transporter 2 InhibitorsLiver CirrhosisCirrhosisNCT05013502Stanford University14
尚未招募
Unknown
It is study on what happens to patients with liver disease who are hospitalized because their condition suddenly worsens.CTRI/2024/02/062896Govind Ballabh Pant Institute of Post Graduate Medical Education and Research
已完成
3 期
Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and AlbuminCirrhosisNCT00986817Assistance Publique - Hôpitaux de Paris82